175 related articles for article (PubMed ID: 19398134)
1. The short-term effect of acetylcholinesterase inhibitor on the regional cerebral blood flow of Alzheimer's disease.
Cho H; Kwon JH; Seo HJ; Kim JS
Arch Gerontol Geriatr; 2010; 50(2):222-6. PubMed ID: 19398134
[TBL] [Abstract][Full Text] [Related]
2. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
[TBL] [Abstract][Full Text] [Related]
3. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
Shimizu S; Hanyu H; Iwamoto T; Koizumi K; Abe K
J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
[TBL] [Abstract][Full Text] [Related]
4. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
[TBL] [Abstract][Full Text] [Related]
6. [The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years].
Lipczyńska-Łojkowska W; Ryglewicz D; Jedrzejczak T; Jakubowska T; Kotapka-Minc S; Sienkiewicz-Jarosz H; Bochyńska A
Neurol Neurochir Pol; 2004; 38(6):471-81. PubMed ID: 15654671
[TBL] [Abstract][Full Text] [Related]
7. The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
Lojkowska W; Ryglewicz D; Jedrzejczak T; Minc S; Jakubowska T; Jarosz H; Bochynska A
J Neurol Sci; 2003 Dec; 216(1):119-26. PubMed ID: 14607313
[TBL] [Abstract][Full Text] [Related]
8. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
Nakano S; Asada T; Matsuda H; Uno M; Takasaki M
J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
Iizuka T; Kameyama M
Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a high dosage of donepezil for Alzheimer's disease as examined by single-photon emission computed tomography imaging.
Kanaya K; Abe S; Sakai M; Fujii H; Koizumi K; Iwamoto T
Psychogeriatrics; 2012 Sep; 12(3):172-8. PubMed ID: 22994615
[TBL] [Abstract][Full Text] [Related]
11. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
[TBL] [Abstract][Full Text] [Related]
12. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
[TBL] [Abstract][Full Text] [Related]
13. Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease.
Cerci SS; Tamam Y; Kaya H; Yildiz M; Arslan S
Adv Ther; 2007; 24(3):611-21. PubMed ID: 17660172
[TBL] [Abstract][Full Text] [Related]
14. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
[TBL] [Abstract][Full Text] [Related]
15. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
Takahashi M; Oda Y; Okubo T; Shirayama Y
J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077
[TBL] [Abstract][Full Text] [Related]
16. Relationship between clock drawing test performance and regional cerebral blood flow in Alzheimer's disease: a single photon emission computed tomography study.
Ueda H; Kitabayashi Y; Narumoto J; Nakamura K; Kita H; Kishikawa Y; Fukui K
Psychiatry Clin Neurosci; 2002 Feb; 56(1):25-9. PubMed ID: 11929568
[TBL] [Abstract][Full Text] [Related]
17. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
Ceravolo R; Volterrani D; Tognoni G; Dell'Agnello G; Manca G; Kiferle L; Rossi C; Logi C; Strauss HW; Mariani G; Murri L
Clin Neuropharmacol; 2004; 27(4):166-70. PubMed ID: 15319702
[TBL] [Abstract][Full Text] [Related]
18. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
[TBL] [Abstract][Full Text] [Related]
19. Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study.
Sakai M; Hanyu H; Kume K; Sato T; Hirao K; Kanetaka H; Abe S; Kanaya K; Sakurai H; Iwamoto T
Geriatr Gerontol Int; 2013 Jul; 13(3):555-62. PubMed ID: 22963387
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
